“The North American ophthalmology cataract surgery devices market is estimated to witness a CAGR of 7.8% during the forecast period, 2014 to 2019. The U.S. dominated the North American ophthalmology cataract surgery devices market in 2014 and accounted for a market share of 91.6%. The North American ophthalmology cataract surgery devices market is expected to witness growth in the coming years as well owing to the increasing strategic expansion of the companies and continuous rise in the aging population. However, the economic slowdown and saturation of the market are some of the factors limiting the growth of the North American ophthalmology cataract surgery devices market.
In this report, the North American ophthalmology cataract surgery devices market is broadly classified by end-user and submarket. Geographically the market is divided into the U.S., Canada, and Mexico. The U.S. led the North American ophthalmology cataract surgery devices market in 2014, followed by Canada.
The report has profiled the leading players of this market along with recent developments, such as, new product launches, partnerships, agreements, collaborations, and joint ventures. It also provides information on the strategies adopted by these leading market players to sustain and strengthen their position in the North American ophthalmology cataract surgery devices market. Abbott Laboratories (U.S.), Alcon, Inc., Allergan, Inc. (U.S.), Bausch & Lomb, Inc. (U.S.), Carl Zeiss Meditech AG (Germany), Essilor International S.A. (France), NIDEK Co., Ltd. (Japan), Topcon Corporation (Japan), and STAAR Surgical Company (U.S.) are some of the key players operating in this market.
“
